A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs

Vistakon Pharmaceuticals

Status

Completed

Conditions

Open-angle Glaucoma

Ocular Hypertension

Treatments

Drug: timolol hemihydrate

Drug: timolol maleate

Study type

Observational

Funder types

Industry

Identifiers

NCT00823043

VPH0110

Details and patient eligibility

About

The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle glaucoma or ocular hypertension were asked to complete a survey regarding their normal treatment. No treatment was prescribed.

Enrollment

103 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

willing to comply with investigator's and protocol's instructions
patients signature on the informed consent document
open-angle glaucoma or ocular hypertension
currently prescribed timolol hemihydrate (once a day (QD) or twice a day (BID))or timolol maleate in sorbate QD as monotherapy or as a part of 2-drug therapy in at least one eye

Exclusion criteria

inability to understand the trial procedures
inability to give informed consent
inability to understand, read, or write English
best corrected visual acuity of 20/200 or worse in each eye
current moderate to severe infectious or inflammatory condition of the eye or eyelids including
current moderate to severe dry eye syndrome
current chronic use of ocular corticosteroids, ocular surgery or intraocular laser surgery to either eye in the prior 3 months
treated with 3 or more glaucoma medicines in both eye